Published Papers & Misc - YOSHIDA Soichiro

Division display  41 - 60 of about 205 ／  All the affair displays >>

  1. Maruyama R, Fukushima H, Fukuda S, Yasuda Y, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Kihara K, Fujii Y. Nonuse of antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: Results of the risk-based strategy in 1362 consecutive patients. International journal of urology : official journal of the Japanese Urological Association. 2021.07; ( PubMed, DOI )

  2. Yoshida S, Matsuoka Y, Toda K, Uehara S, Tanaka H, Yokoyama M, Saito K, Yoshimura R, Fujii Y. Nonmetastatic castration-resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy. IJU case reports. 2021.07; 4 (4): 228-230. ( PubMed, DOI )

  3. Saito K, Matsuoka Y, Toda K, Yoshida S, Yokoyama M, Yoshimura R, Kihara K, Fujii Y. Medium-term oncological and functional outcomes of hemi-gland brachytherapy using iodine-125 seeds for intermediate-risk unilateral prostate cancer. Brachytherapy. 2021.07; 20 (4): 842-848. ( PubMed, DOI )

  4. Yoshida S, Fujii Y. Editorial Comment to Long-term clinical outcomes of external beam radiation therapy for oligometastatic prostate cancer: A combination of prostate-targeted treatment and metastasis-directed therapy. International journal of urology : official journal of the Japanese Urological Association. 2021.07; 28 (7): 756. ( PubMed, DOI )

  5. Yoshida S, Takahara T, Arita Y, Toda K, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y. Genuine- and induced-oligometastatic castration-resistant prostate cancer: clinical features and clinical outcomes after progressive site-directed therapy. International urology and nephrology. 2021.06; 53 (6): 1119-1125. ( PubMed, DOI )

  6. Kimura K, Yoshida S, Tsuchiya J, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Tateishi U, Fujii Y. Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer. European radiology. 2021.06; ( PubMed, DOI )

  7. Yamazaki A, Ito T, Sugimoto M, Yoshida S, Honda K, Kawashima Y, Fujikawa T, Fujii Y, Tsutsumi T. Patient-specific virtual and mixed reality for immersive, experiential anatomy education and for surgical planning in temporal bone surgery. Auris, nasus, larynx. 2021.05; ( PubMed, DOI )

  8. Yoshida S, Takahara T, Arita Y, Sakaino S, Katahira K, Fujii Y. Whole-body diffusion-weighted magnetic resonance imaging: Diagnosis and follow up of prostate cancer and beyond. International journal of urology : official journal of the Japanese Urological Association. 2021.05; 28 (5): 502-513. ( PubMed, DOI )

  9. Arita Y, Yoshida S, Waseda Y, Takahara T, Ishii C, Ueda R, Kwee TC, Miyahira K, Ishii R, Okuda S, Jinzaki M, Fujii Y. Diagnostic value of computed high b-value whole-body diffusion-weighted imaging for primary prostate cancer. European journal of radiology. 2021.04; 137 109581. ( PubMed, DOI )

  10. Yasuda Yosuke, Saito Kazutaka, Tanaka Hajime, Uehara Sho, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa. Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique(和訳中) International Journal of Urology. 2021.03; 28 (3): 302-307. ( ichushi )

  11. Yoshida S, Fujii Y. Editorial Comment to Utility of whole-body diffusion-weighted magnetic resonance imaging in the management of treatment-related neuroendocrine prostate cancer. IJU case reports. 2021.03; 4 (2): 73-74. ( PubMed, DOI )

  12. Yoshida Soichiro, Fujii Yasuhisa. Editorial Comment to Utility of whole-body diffusion-weighted magnetic resonance imaging in the management of treatment-related neuroendocrine prostate cancer(和訳中) IJU Case Reports. 2021.03; 4 (2): 73-74. ( ichushi )

  13. Fukuda S, Saito K, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Kageyama Y, Fujii Y. Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab. Journal for immunotherapy of cancer. 2021.02; 9 (2): ( PubMed, DOI )

  14. Yoshida Soichiro, Takahara Taro, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa. Can progressive site-directed therapy prolong the efficacy of subsequent androgen receptor axis-targeted drugs in oligometastatic castration-resistant prostate cancer?(和訳中) International Journal of Urology. 2021.02; 28 (2): 241-242. ( ichushi )

  15. Yoshida S, Matsushima H, Fujii Y. Classification of oligometastatic prostate cancer with additional consideration for hormone sensitivity. World journal of urology. 2021.01; ( PubMed, DOI )

  16. Soma T, Yokoyama M, Uchida Y, Kirimura S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y. Long-term survival after radical cystectomy and mesenteric lymph node dissection for squamous cell carcinoma arising from augmented bladder with lymph node metastasis: a case report. International cancer conference journal. 2021.01; 10 (1): 20-23. ( PubMed, DOI )

  17. Fukushima H, Yoshida S, Kijima T, Nakamura Y, Fukuda S, Uehara S, Yasuda Y, Tanaka H, Yokoyama M, Matsuoka Y, Fujii Y. Combination of Cisplatin and Irradiation Induces Immunogenic Cell Death and Potentiates Postirradiation Anti-PD-1 Treatment Efficacy in Urothelial Carcinoma. International journal of molecular sciences. 2021.01; 22 (2): ( PubMed, DOI )

  18. Matsuoka Yoh, Uehara Sho, Yoshida Soichiro, Tanaka Hajime, Yokoyama Minato, Fujii Yasuhisa. Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy: Potential of target margin and surrounding region sampling using magnetic resonance-ultrasound image fusion systems(和訳中) International Journal of Urology. 2021.01; 28 (1): 127-129. ( ichushi )

  19. Waseda Y, Yoshida S, Arita Y, Takahara T, Sakamoto T, Saito K, Fujii Y. Potential of Perfusion Magnetic Resonance Imaging to Predict Residual Renal Function after Radical Nephroureterectomy. Urologia internationalis. 2021; 105 (5-6): 507-513. ( PubMed, DOI )

  20. Yasuda Y, Saito K, Tanaka H, Uehara S, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Kihara K, Fujii Y. Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique. International journal of urology : official journal of the Japanese Urological Association. 2020.12; ( PubMed, DOI )

< PREV - NEXT >

To the head of this page.▲